drugset / Trial / NCT06352190
A Study to Evaluate the Mass Balance of [14C] SY-5007 in Healthy Adult Male Subjects in China
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, open-label, non-randomized, single dose study in healthy male subjects designed to assess mass balance recovery, metabolite profile and metabolite identification of radio-labeled SY-5007 administered orally.
Timeline
- Start
- 2024-05-01
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SY-5007 | Unknown | 160 mg | Oral |
Indications
No indication recorded.